Aethlon Medical (AEMD) Net Cash Flow (2010 - 2026)

Aethlon Medical's Net Cash Flow history runs 17 years deep, the most recent figure standing at -$1.9 million for Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow fell 383.03% year-over-year to -$1.9 million; the trailing twelve-month figure through Mar 2026 stood at $6.6 million (down 22.77% YoY), and the FY2026 full-year result was -$480192.0, down 686.66% from the prior year.
• Net Cash Flow was -$1.9 million for Q1 2026 at Aethlon Medical, down from $4.9 million in the prior quarter.
• Over the last five years, Net Cash Flow for AEMD reached as high as $5.4 million in Q3 2025 and fell as low as -$3.3 million in Q1 2022.
• Median Net Cash Flow over the past 5 years was -$1.7 million (2025), compared with a mean of $10177.9.
• Across the five-year window, Net Cash Flow soared 340.52% in 2022 and sank 383.03% in 2026, its largest moves.
• Over 5 years, Net Cash Flow stood at -$2.1 million in 2022, then fell by 4.99% to -$2.2 million in 2023, then soared by 190.6% to $2.0 million in 2024, then jumped by 142.82% to $4.9 million in 2025, then plunged by 140.1% to -$1.9 million in 2026.
• Business Quant data shows AEMD's Net Cash Flow at -$1.9 million in Q1 2026, $4.9 million in Q4 2025, and $5.4 million in Q3 2025.